NDC 68727-150

XYWAV

(calcium, Magnesium, Potassium, And Sodium Oxybates)

XYWAV is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Sodium Oxybate; Calcium Oxybate; Potassium Oxybate; Magnesium Oxybate.

• Product ID: 68727-150_128ed05a-6bef-4f3e-a6a6-3e88f04aa86c
• NDC: 68727-150
• Product Type: Human Prescription Drug
• Proprietary Name: XYWAV
• Generic Name: (calcium, Magnesium, Potassium, And Sodium Oxybates)
• Dosage Form: Solution
• Route of Administration: ORAL
• Marketing Start Date: 2020-11-02
• Marketing Category: NDA / NDA
• Application Number: NDA212690
• Labeler Name: Jazz Pharmaceuticals, Inc.
• Substance Name: SODIUM OXYBATE; CALCIUM OXYBATE; POTASSIUM OXYBATE; MAGNESIUM OXYBATE
• Active Ingredient Strength: 1 g/mL; g/mL; g/mL; g/mL
• Pharm Classes: Central Nervous System Depressant [EPC],Central Nervous System Depression [PE],Decreased Central Nervous System Organized Electrical Activity [PE],Central Nervous System Depressant [EPC],Central Nervous System Depression [PE],Decreased Central Nervous System Organized Electrical Activity [PE],Central Nervous System Depressant [EPC],Central Nervous System Depression [PE],Decreased Central Nervous System Organized Electrical Activity [PE],Central Nervous System Depressant [EPC],Central Nervous System Depression [PE],Decreased Central Nervous System Organized Electrical Activity [PE]
• DEA Schedule: CIII
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 68727-150-01

180 mL in 1 BOTTLE, PLASTIC (68727-150-01)

• Marketing Start Date: 2020-11-02
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details